MedPath

EXONEURAL NETWORK AB

πŸ‡ΈπŸ‡ͺSweden
Ownership
Holding
Employees
-
Market Cap
-
Website
http://www.exopulse.com

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
1 (100.0%)

The Exopulse Mollii Suit Study - a Database for Routine Follow-up of Clinical Outcomes

Not yet recruiting
Conditions
Neurologic Disorder
Spinal Cord Injuries
Cerebral Palsy
Multiple Sclerosis
Stroke
First Posted Date
2023-06-13
Last Posted Date
2023-09-13
Lead Sponsor
Exoneural Network AB
Target Recruit Count
200
Registration Number
NCT05901259
Locations
πŸ‡ΈπŸ‡ͺ

Exoneural Network Ab, Bergshamra, Stockholm, Sweden

Exopulse Mollii Suit, Motor Functions & CP Children With Cerebral Palsy

Not Applicable
Recruiting
Conditions
Spasticity
Muscle
Diplegia
Tetraplegia
Balance
Hemiplegia
Cerebral Palsy
Pain Syndrome
First Posted Date
2023-06-01
Last Posted Date
2024-01-30
Lead Sponsor
Exoneural Network AB
Target Recruit Count
34
Registration Number
NCT05885139
Locations
πŸ‡©πŸ‡ͺ

Pohlig GmbH, Traunstein, Bavaria, Germany

πŸ‡©πŸ‡ͺ

Medizinische Hochschule Hannover (MHH), Hanover, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.